Rani Therapeutics is a Biotech company based in San Jose, CA. It has raised $202M in total funding. Latest round: Growth.
Rani Therapeutics funding overview
Rani Therapeutics is a Biotech company based in San Jose, CA. Rani Therapeutics has raised $202M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in October 2025. The round record for Rani Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include AstraZeneca, Novartis, Google Ventures, GV, Ping An Ventures, Virtus Inspire Ventures and 6 others. 12 distinct backers are named across the disclosed rounds.
Rani Therapeutics at a glance
Total raised
$202M
Latest round
Growth
Latest round date
October 2025
Industry
Biotech
Headquarters
San Jose, CA
Notable investors
AstraZeneca, Novartis, Google Ventures, GV, Ping An Ventures, Virtus Inspire Ventures, RA Capital Management, Samsara
Frequently asked about Rani Therapeutics funding
How much has Rani Therapeutics raised?
Rani Therapeutics has raised $202M in total disclosed funding across the rounds on record.
Who has invested in Rani Therapeutics?
AstraZeneca, Novartis, Google Ventures, GV, Ping An Ventures, Virtus Inspire Ventures are named among the investors backing Rani Therapeutics.
What was the latest Rani Therapeutics funding round?
The most recent disclosed round is a Growth, announced in October 2025.
Where is Rani Therapeutics based?
Rani Therapeutics is based in San Jose, CA.
What sector does Rani Therapeutics operate in?
Rani Therapeutics is tracked under Biotech from San Jose, CA, with $202M in disclosed funding.
When did Rani Therapeutics last raise?
The last disclosed Rani Therapeutics round closed in October 2025 at Growth.
We update the Rani Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in San Jose and their backers are listed below.
